Shares in Resonance Health have doubled today after its FerriSmart technology, which uses machine learning to quantify liver iron concentration, received FDA approval.

Shares in Resonance Health have doubled today after its FerriSmart technology, which uses machine learning to quantify liver iron concentration, received FDA approval.